electroCore's Active Role in Upcoming Investor Conferences
ROCKAWAY, N.J. — electroCore, Inc. (NASDAQ: ECOR), a recognized leader in bioelectronic medicine and wellness solutions, is gearing up to engage with investors through participation in major investor conferences. These events present an excellent opportunity for the company to showcase its innovations and connect on a personal level with stakeholders.
Needham Annual Virtual MedTech Conference
One of the highlights of electroCore's schedule is the Needham 10th Annual Virtual MedTech and Diagnostics Conference. This event will occur on August 11 and August 12, 2025. Management is enthusiastic about hosting one-on-one meetings, allowing investors to explore the company's cutting-edge technology and its implications for the future of healthcare.
Connect Virtually with ElectroCore
During the virtual conference, management will be available for personalized discussions, offering investors insights into the company's strategic direction, innovative products, and overall market positioning in bioelectronic medicine.
Canaccord Genuity Annual Growth Conference
In addition to the Needham conference, electroCore will also participate in the Canaccord Genuity 45th Annual Growth Conference held in Massachusetts from August 12 to August 13, 2025. The company is set to present on August 12 at 3:30 p.m. ET, a valuable opportunity for stakeholders to gain a comprehensive understanding of its growth strategy and product efficacy in treating chronic pain.
Meet the Management Team
Following the presentation, there will be additional one-on-one meetings, allowing attendees to engage directly with electroCore's management team. This interaction is vital as it helps clarify the company’s vision and commitment to improving health through innovative neurostimulation technologies.
About ElectroCore, Inc.
Founded with the mission to enhance the quality of life through non-invasive bioelectronic technologies, electroCore is at the forefront of developing solutions for chronic conditions. Its flagship products, gammaCore and Quell, utilize neuromodulation technology to alleviate chronic pain syndromes. In addition, the company’s Truvaga line promotes overall wellness and personal performance through advanced bioelectronic means.
Innovative Technologies for Improved Health
ElectroCore is committed to pushing the boundaries of what is possible in bioelectronic health solutions. The growing recognition of their products reflects a significant advancement in non-invasive therapies to support wellness and improve the patient experience.
Contact Information
Investors interested in meeting with electroCore's representatives during the conferences are encouraged to reach out. Contact your sales representative or connect directly with electroCore Investor Relations at ecor@fnkir.com.
For further insights on electroCore's innovative offerings or the upcoming conferences, please visit www.electrocore.com.
Frequently Asked Questions
What is electroCore's primary focus in the healthcare industry?
ElectroCore focuses on developing non-invasive bioelectronic solutions to manage chronic pain and enhance overall wellness.
When will electroCore participate in upcoming investor conferences?
ElectroCore will participate in the Needham Virtual MedTech Conference on August 11 and 12, and the Canaccord Genuity Growth Conference on August 12 and 13, 2025.
How can investors reach out for meetings with electroCore's management?
Investors can request meetings by contacting their sales representatives or emailing electroCore Investor Relations at ecor@fnkir.com.
What products does electroCore offer?
ElectroCore offers products like gammaCore and Quell, utilizing neuromodulation technology to address chronic pain syndromes effectively.
Where can I find more information about electroCore's innovations?
For more information on electroCore's innovative solutions and updates, you can visit their official website at www.electrocore.com.
